Yongmei Xu
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$3.5MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jan 28, 2020 | NIH | STTR Phase II LC-MS System to Determine the Molecular Mass of Synthesized Heparan and Chondroitin Sulfate Oligosaccharides | $120K | GLYCAN THERAPEUTICS CORPORATION |
| Nov 26, 2019 | NIH | STTR Phase II Enzymatic synthesis of heparin sulfate and chondroitin sulfate | $736K | GLYCAN THERAPEUTICS CORPORATION |
| Dec 1, 2018 | NIH | STTR Phase II LC-MS System to Determine the Molecular Mass of Synthesized Heparan and Chondroitin Sulfate Oligosaccharides | $1.6M | GLYCAN THERAPEUTICS CORPORATION with UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| Nov 27, 2018 | NIH | STTR Phase II Enzymatic synthesis of heparin sulfate and chondroitin sulfate | $744K | GLYCAN THERAPEUTICS CORPORATION |
| Sep 19, 2018 | NIH | STTR Phase II Reactor for Insect Cell Culture | $110K | GLYCAN THERAPEUTICS CORPORATION |
| Mar 30, 2018 | NIH | STTR Phase II Enzymatic synthesis of heparin sulfate and chondroitin sulfate | $225K | GLYCAN THERAPEUTICS CORPORATION |
Peer ranks
Federal funding#487
Awards as PI#315
Patents#273
Companies
- GLYCAN THERAPEUTICS CORPORATIONLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.